Jim Hu, MD
Urology · New York, NYNPI 1972558583
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (28.5%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 16 manufacturers reported payments, led by Intuitive Surgical at 50.1% of the total. Reporting peaked in 2024 at $9,328 and has fallen 74.9% since, to $2,343 in 2025. Among urology clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 119 payments — averaging $279.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$17K
- Pfizer$5K
- Janssen Scientific Affairs, LLC$4K
- EDAP Technomed Inc$2K
- Astellas Pharma US Inc$2K
- Janssen Research & Development, LLC$1K
- plus $3K from 10 others
Across 2 payments — averaging $11,188 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Janssen Research & Development, LLC$19K
- Ortho-clinical Diagnostics, Inc.$4K
What the payments were for
- Consulting fees$5,71517%
- Speaking & faculty fees$3,90012%
- Travel & lodging$7,30722%
- Food & beverage$6,72420%
- Education$9,50029%
- Gifts$90%
- Entertainment$1230%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 58 | $16,674 |
| Pfizer | 15 | $4,929 |
| Janssen Scientific Affairs, LLC | 8 | $3,809 |
| EDAP Technomed Inc | 9 | $2,237 |
| Astellas Pharma US Inc | 2 | $1,945 |
| Janssen Research & Development, LLC | 4 | $1,095 |
| Boston Scientific | 3 | $778 |
| Johnson & Johnson(2 entities) | 4 | $533 |
| Progenics Pharmaceuticals, Inc. | 5 | $333 |
| Koelis Inc. | 2 | $271 |
| Axogen | 2 | $257 |
| Urogen Pharma, Inc. | 1 | $180 |
| Hitachi Healthcare Americas Corp. | 2 | $123 |
| Smith+Nephew | 2 | $64 |
| Galvanize Therapeutics, Inc | 1 | $27 |
| Blue Earth Diagnostics | 1 | $24 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$14,258
- XTANDI$6,521
- Erleada$3,996
- FOCAL ONE$1,501
- DA VINCI SP$1,500
- ORGOVYX$1,111
- Moses 550 D\F\L$709
- TALZENNA$637
- Trinity 3D Prostate Suite$271
- PYLARIFY$239
- STRATAFIX$136
- SURGICEL NU-KNIT$136
- Echelon Flex$136
How this compares
$33,278 in reported general payments places this provider in the 90th percentile of 952 urology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tamsulosin Hcl | 25 | $398 |
| Finasteride | 15 | $338 |
| Levofloxacin | 65 | $68 |
Paid to pharmacies, not to this prescriber.
Other urology in New York
- Bilal ChughtaiNew York$658K
- Katie MurrayNew York$575K
- Neil BanderNew York$544K
- Robert ValenzuelaNew York$494K
- Kyrollis AttallaNew York$381K
- Benjamin BruckerNew York$364K
- Ketan BadaniNew York$285K
- Michael GrassoNew York$284K
- Mantu GuptaNew York$229K
- Robin SmithNew York$215K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.